News & Publications


Learn more about Prous Institute and our progress in drug discovery, technology, industry partnerships, collaborations and scientific articles.

Identification of structure-activity relationships for adverse effects of pharmaceuticals in humans

2010 Nov 06 |

Part C: use of QSAR and an expert system for the estimation of the mechanism of action of drug-induced hepatobiliary and urinary tract toxicities. 

Describes the regulatory use of BioEpisteme and other predictive systems.

Authors: Matthews EJ, Kruhlak NL, Benz RD, Aragonés Sabaté D, Marchant CA, Contrera JF.

Journal: Regul Toxicol Pharmacol. 2009 Jun;54(1):43-65, PMID: 19422100

Link to Article

Related Articles

New Research Collaboration Agreement (RCA) between Prous Institute and the FDA-CFSAN (Center for Food Safety and Applied Nutrition) Washington D.C., USA: The Food and Drug Administration's Center for Food Safety and Applied Nutrition(FDA/CFSAN) and Prous Institute for Biomedical Re...
Prous Institute Presents Its Progress in Cardiotoxicity Modeling at the SOT 2011 Washington D.C., USA: Prous Institute for Biomedical Research will be jointly presenting a scientific poster with the US FDA Center for Drug Evaluatio...
SOT 2011: “In Silico Predictive Model for Drug-Induced Phospholipidosis using BioEpisteme software" Washington D.C., USA: Prous Institute’s BioEpisteme® software will be featured in a scientific poster to be presented by the US FDA Center f...
Prediction of Drug-Related Cardiac Adverse Effects in Humans--A: Creation of a Database of Effects and Identification of Factors Affecting their Occurrence. Authors: Matthews EJ, Frid AA. Journal: Regul Toxicol Pharmacol. 2010 Apr;56(3):247-75., PMID: 19932726 Link to Article
Prediction of Drug-Related Cardiac Adverse Effects in Humans--B: Use of QSAR Programs for Early Detection of Drug-Induced Cardiac Toxicities Authors: Frid AA, Matthews EJ Journal: Regul Toxicol Pharmacol. 2010 Apr;56(3):276-89., PMID: 19941924 Link to Article